J1836 HCPCS code: Injection, metronidazole, 10 mg
J1836 is the HCPCS Level II code for injection, metronidazole, 10 mg. In 2024 Medicare paid an average of $0.02 per service for J1836 across 33,481 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 400 per day on outpatient hospital claims. Medicare volume rose 539% from 2023 to 2024 (5,242 to 33,481 services). In 2024, about 120 clinicians billed Medicare for J1836 for 286 beneficiaries; Texas, California, New York accounted for 75% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-07-01 |
| Last action effective | 2024-01-01 |
Who bills J1836 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 120 |
| Medicare beneficiaries | 286 |
| States with claims | 9 |
| Share of services in top 3 states (Texas, California, New York) | 75% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1836, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 5,242 | 78 | $0.02 | $0.02 |
| 2024 | 33,481 | 286 | $0.03 | $0.02 |
States with the most J1836 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 9,954 | $0.02 |
| California | 5,200 | $0.02 |
| New York | 2,473 | $0.02 |
| New Jersey | 2,453 | $0.02 |
| Illinois | 820 | $0.02 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 400 | Prescribing Information |
| practitioner claims | 400 | Prescribing Information |
What changed for J1836
- 2023-07-01: J1836 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1836?
J1836 is the HCPCS Level II code for injection, metronidazole, 10 mg. Short descriptor: "Inj, metronidazole, 10 mg".
How much does Medicare pay for J1836?
In 2024, the average Medicare payment was $0.02 per service (average allowed $0.03).
Does Medicare cover J1836?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1836 can be billed per day?
400 on outpatient hospital claims; 400 on practitioner claims (NCCI medically unlikely edits).
Related J18 codes
- J1800 — Injection, propranolol hcl, up to 1 mg
- J1805 — Injection, esmolol hydrochloride, 10 mg
- J1806 — Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg
- J1807 — Injection, ethacrynate sodium, 1 mg
- J1808 — Injection, folic acid, 0.1 mg
- J1809 — Injection, fosdenopterin, 0.1 mg
- J1810 — Injection, droperidol and fentanyl citrate, up to 2 ml ampule
- J1811 — Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
- J1812 — Insulin (fiasp), per 5 units
- J1813 — Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
- J1814 — Insulin (lyumjev), per 5 units
- J1815 — Injection, insulin, per 5 units
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1836
- Watch J1836 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1836
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.